Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson
Mallinckrodt
Colorcon
Boehringer Ingelheim

Last Updated: March 24, 2023

Heritage Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for HERITAGE PHARMS, and what generic and branded alternatives to HERITAGE PHARMS drugs are available?

HERITAGE PHARMS has thirty-eight approved drugs.



Summary for Heritage Pharms
US Patents:0
Tradenames:34
Ingredients:33
NDAs:38

Drugs and US Patents for Heritage Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 078728-003 Jun 23, 2010 AB RX No No See Plans and Pricing See Plans and Pricing
Heritage Pharms VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET;ORAL 071881-002 Oct 14, 2015 AB RX No No See Plans and Pricing See Plans and Pricing
Heritage Pharms Inc METRONIDAZOLE metronidazole TABLET;ORAL 205245-002 Sep 23, 2015 AB RX No No See Plans and Pricing See Plans and Pricing
Heritage Pharms NYSTATIN nystatin TABLET;ORAL 062474-001 Dec 22, 1983 AA RX No No See Plans and Pricing See Plans and Pricing
Heritage Pharms Inc DOLENE propoxyphene hydrochloride CAPSULE;ORAL 080530-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Heritage Pharms VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET;ORAL 071881-001 Apr 5, 1988 AB RX No Yes See Plans and Pricing See Plans and Pricing
Heritage Pharms NIMODIPINE nimodipine CAPSULE;ORAL 077811-001 May 2, 2007 AB RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Heritage Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Heritage Pharms Inc LIMBITROL amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-001 Approved Prior to Jan 1, 1982 4,316,897 See Plans and Pricing
Heritage Pharms Inc LIMBITROL DS amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-002 Approved Prior to Jan 1, 1982 4,316,897 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Merck
Boehringer Ingelheim
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.